ertapenem has been researched along with Experimental Lung Inflammation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelraouf, K; Chen, I; Gethers, M; Nicolau, DP | 1 |
| Bai, N; Cai, Y; Liang, B; Liu, Y; Sun, C; Wang, J; Wang, R; Zhang, L | 1 |
| Bravo-Ferrer, JM; Gutiérrez-Urbón, JM; Llinares, P; Pita, S; Ramos-Merino, L; Seoane-Pillado, T; Sousa, D; Vázquez-Rodríguez, P | 1 |
| Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N | 1 |
| Aguilar, L; Barberán, J; González-Comeche, J; González-Moreno, J; González-Pina, B; Granizo, JJ; Irurzun, J; López-Dupla, M; Marín, A; Murcia, JM | 1 |
| Blain, H; Durant, R; Jeandel, C; Raschilas, F; Tigoulet, F | 1 |
1 review(s) available for ertapenem and Experimental Lung Inflammation
| Article | Year |
|---|---|
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Ertapenem; Humans; Intraabdominal Infections; Pneumonia; Randomized Controlled Trials as Topic; Urinary Tract Infections | 2014 |
6 other study(ies) available for ertapenem and Experimental Lung Inflammation
| Article | Year |
|---|---|
In vivo efficacy of WCK 6777 (ertapenem/zidebactam) against carbapenemase-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cyclooctanes; Ertapenem; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Piperidines; Pneumonia | 2022 |
The use of ertapenem for the treatment of community-acquired pneumonia in routine hospital practice: a matched cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Comorbidity; Ertapenem; Female; Frail Elderly; Hospitalization; Humans; Male; Middle Aged; Nursing Homes; Pneumonia; Retrospective Studies; Risk Factors | 2016 |
Levofloxacin-induced delirium.
Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment | 2009 |
Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Community-Acquired Infections; Ertapenem; Female; Hospitals; Humans; Length of Stay; Male; Pneumonia; Retrospective Studies; Severity of Illness Index; Spain; Treatment Outcome | 2009 |
Ertapanem therapy for community-acquired pneumonia in the elderly.
Topics: Aged; beta-Lactams; Community-Acquired Infections; Ertapenem; Humans; Lactams; Pneumonia | 2004 |
Ertapenem (Invanz)--a new parenteral carbapenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Ertapenem; Gram-Negative Bacterial Infections; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Lactams; Pneumonia; Urinary Tract Infections | 2002 |